MODAHEAL – Potency Product | Buy in Ukraine with Delivery

What is MODAHEAL?

MODAHEAL is a medicinal product belonging to the pharmacological group of psychostimulants and nootropics with a pronounced eugeroic effect, meaning the ability to maintain a state of wakefulness without excessive excitation of the nervous system. The main active substance of the drug is modafinil, which is used for the treatment of excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder. The manufacturer of MODAHEAL is the Indian pharmaceutical company Healing Pharma, which specializes in the production of high-quality generic drugs in compliance with international GMP standards. The medication is released in the form of tablets for oral administration, which ensures convenient dosing and high bioavailability of the active component.

MODAHEAL stands out among classic amphetamine-type psychostimulants due to its significantly milder action profile and lower risk of developing dependence, making it an acceptable option for long-term therapy of chronic sleep-wake disorders. The mechanism of action of modafinil consists in the selective activation of specific areas of the hypothalamus responsible for the regulation of the sleep-wake cycle, without a significant impact on the peripheral nervous system. Thanks to such targeted action, the drug helps patients maintain mental clarity, concentration, and working capacity throughout the day. Clinical studies confirm that MODAHEAL effectively reduces episodes of uncontrollable falling asleep and improves the overall quality of life of patients with hypersomnia. It is important to understand that the medication does not replace full night's sleep, but only corrects pathological daytime sleepiness.

In the pharmaceutical market of Ukraine, MODAHEAL is positioned as an affordable generic analog of the original modafinil drug, allowing patients to obtain a therapeutic effect at a more reasonable price. The drug is dispensed by prescription, as it belongs to the category of prescription medicines requiring medical supervision and justified indication. Before starting to take MODAHEAL, it is necessary to undergo a comprehensive examination to determine the exact cause of daytime sleepiness and to exclude other somatic or psychiatric pathologies. Self-medication with this drug is unacceptable, as improper dosage can lead to undesirable consequences for the cardiovascular and nervous systems.

What is MODAHEAL prescribed for?

The primary indication for prescribing MODAHEAL is narcolepsy — a chronic neurological disorder characterized by irresistible attacks of daytime sleep, sudden loss of muscle tone, and nighttime sleep disturbances. In patients with this diagnosis, the drug helps maintain a stable level of wakefulness during the active part of the day, reducing the frequency and intensity of sudden sleep episodes. MODAHEAL does not eliminate all symptoms of narcolepsy, such as cataplexy, but significantly improves the patient's ability to engage in social and professional activities. The therapeutic effect develops gradually, so it is important to adhere to regular intake according to the prescribed regimen.

The second significant indication is obstructive sleep apnea syndrome, in which patients suffer from chronic daytime fatigue and sleepiness due to repeated breathing pauses during nighttime sleep. MODAHEAL is used as an adjunctive treatment in combination with the primary therapy — continuous positive airway pressure (CPAP) therapy, when daytime sleepiness persists despite adequate breathing correction. The drug allows patients to remain alert and attentive during the day, which is especially important for drivers and workers whose activities require increased concentration. Prescribing MODAHEAL in such cases is performed only after confirming the diagnosis with a polysomnographic study.

MODAHEAL is also effective for shift work sleep disorder, when professional activity involves regular night shifts or frequent changes of time zones, leading to desynchronization of circadian rhythms. In such patients, the drug helps adapt the body to a non-standard wakefulness schedule, reducing feelings of exhaustion and improving cognitive functions during working hours. In addition, in certain clinical situations, MODAHEAL may be prescribed off-label for the treatment of chronic fatigue syndrome, depressive states with pronounced asthenia, and cognitive impairments; however, such use requires special caution and careful medical supervision. In each case, the decision on the appropriateness of therapy is made exclusively by a qualified specialist based on the individual clinical picture.

Composition and active components of MODAHEAL

Each MODAHEAL tablet contains modafinil at a dosage of 200 mg, which is the standard therapeutic dose for adult patients. Modafinil is a synthetic compound from the benzhydrylsulfinylacetamide group, which differs significantly in chemical structure from classic central nervous system stimulants. The mechanism of action of the active substance is realized through the inhibition of dopamine reuptake in the synaptic cleft, which increases the concentration of this neurotransmitter in specific brain areas responsible for wakefulness regulation. At the same time, modafinil affects histamine, norepinephrine, and orexin systems, creating a comprehensive effect of maintaining alertness without pronounced euphoria or psychomotor agitation.

Excipients of MODAHEAL tablets include lactose monohydrate, microcrystalline cellulose, corn starch, povidone, magnesium stearate, and talc, which provide proper physicochemical properties of the tablet form, stability of the active substance, and its uniform release in the gastrointestinal tract. Lactose monohydrate acts as a filler, microcrystalline cellulose ensures the tablet's strength, and magnesium stearate facilitates the tableting process. Patients with lactose intolerance should take into account the presence of this component and discuss with their doctor the possibility of using alternative forms of the drug. The manufacturer guarantees compliance of each batch of the drug with international quality standards and bioequivalence to the original product.

The pharmacokinetic characteristics of modafinil as part of MODAHEAL ensure rapid absorption after oral administration, reaching peak plasma concentration within 2–4 hours. The elimination half-life is approximately 12–15 hours, allowing the medication to be taken once daily while maintaining a stable therapeutic effect throughout the day. Metabolism of the active substance occurs mainly in the liver with the participation of cytochrome P450, and elimination of metabolites is carried out by the kidneys. Such a pharmacokinetic profile necessitates dose adjustment in patients with severe hepatic or renal impairment, as well as in elderly individuals.

MODAHEAL Dosage

The standard recommended dose of MODAHEAL for adult patients is 200 mg once daily, usually in the morning, to ensure alertness during the active part of the day and to avoid night sleep disturbances. In narcolepsy and obstructive sleep apnea syndrome, the drug is taken in the morning regardless of food intake, as food does not significantly affect the bioavailability of modafinil, although it may slightly delay its absorption rate. For patients with shift work sleep disorder, the dose is taken one hour before the start of the work shift, allowing the peak concentration of the drug to synchronize with the required activity period. It is important not to exceed the maximum daily dose of 400 mg, as increasing the dose does not lead to a proportional increase in the therapeutic effect, but increases the risk of adverse reactions.

The duration of the MODAHEAL treatment course is determined individually depending on the diagnosis, severity of symptoms, and the patient's response to therapy. In most cases, the drug is prescribed for long-term use; however, the doctor should periodically assess the necessity of continuing therapy and the possibility of dose reduction. Elderly patients, as well as individuals with impaired hepatic function, may require a reduction of the initial dose to 100 mg per day with subsequent titration under the control of clinical response and tolerability. For patients with severe renal failure, the minimum effective doses are recommended due to delayed excretion of drug metabolites.

Dose adjustment of MODAHEAL may be necessary when co-administered with other medications that affect the cytochrome P450 enzyme system, particularly with inducers or inhibitors of these enzymes. Abrupt discontinuation of the drug is usually not accompanied by a pronounced withdrawal syndrome; however, a gradual dose reduction is recommended to avoid the return of excessive sleepiness symptoms. Patients must strictly follow the dosing schedule prescribed by the doctor and not modify it independently, as improper use can reduce the effectiveness of therapy or trigger unwanted reactions.

How to take MODAHEAL correctly?

MODAHEAL should be taken orally with a sufficient amount of water, preferably at the same time each day to maintain a stable drug concentration in the body. The tablet is not recommended to be chewed or crushed, as this may disrupt the uniform release of the active substance and affect the rate of onset of the therapeutic effect. The drug can be taken on an empty stomach or after meals; however, for patients with a sensitive gastrointestinal tract, it is advisable to take the tablet after a light breakfast to reduce the risk of dyspeptic events. It is important to plan the intake of MODAHEAL so that its stimulating effect does not coincide with the period of night rest, as this can cause insomnia and disrupt the natural sleep cycle.

In case of missing a scheduled dose of MODAHEAL, the patient should take it as soon as possible if there is enough time before the next planned intake; however, if the time for the next dose is approaching, the missed dose should be skipped, returning to the regular schedule. Doubling the dose to compensate for a missed one is strictly prohibited, as this can lead to an overdose and the development of serious side effects such as tachycardia, arterial hypertension, psychomotor agitation, and hallucinations. Patients taking MODAHEAL are advised to keep a drug administration diary and record any changes in well-being for further discussion with their doctor. Regular medical follow-up is a mandatory condition for safe therapy, especially during the first months of use.

During MODAHEAL treatment, it is necessary to refrain from consuming alcoholic beverages, as ethanol can potentiate the side effects of the drug on the central nervous system and increase the load on the liver. Caution should also be exercised when driving vehicles and operating complex machinery until individual response to the drug is established, as dizziness or impaired coordination may occur in some patients. Women of childbearing potential taking MODAHEAL must use reliable methods of contraception, as modafinil can reduce the effectiveness of hormonal contraceptives. Any unusual symptoms or worsening of well-being during therapy are a reason for immediate consultation with a doctor.

Side effects of MODAHEAL

The most common side effects of MODAHEAL, observed in more than 5% of patients, are headache, nervousness, anxiety, insomnia, and dry mouth. These symptoms usually occur at the beginning of therapy and tend to decrease or completely disappear during the first weeks of taking the medication. Headache is most often associated with increased central nervous system activity and can be relieved by taking conventional analgesics, but its occurrence should be reported to the doctor. Insomnia develops mainly in patients taking the drug in the second half of the day, so it is important to adhere to a morning intake schedule.

Less common adverse reactions of MODAHEAL include tachycardia, elevated blood pressure, chest pain, palpitations, dizziness, paresthesia, and tremor. Gastrointestinal symptoms may include nausea, diarrhea, abdominal pain, and decreased appetite, sometimes leading to gradual weight loss with prolonged use. Psychiatric disorders, including depressive mood, irritability, aggressiveness, and impaired concentration, have been reported in some patients, requiring careful monitoring of mental status throughout the course of treatment. The onset of any of these symptoms is a reason to consult a doctor to adjust the dose or decide on the appropriateness of continuing therapy.

Rare but potentially serious side effects of MODAHEAL are allergic reactions, including angioedema and anaphylaxis, severe skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis, as well as psychotic episodes. Patients should immediately stop taking the medication and seek emergency medical assistance upon the appearance of rash, itching, swelling of the face, lips, or tongue, difficulty breathing, as well as the development of hallucinations, delusions, or suicidal thoughts. Individual response to the drug can vary significantly, so even in the absence of the listed symptoms, any deterioration in well-being requires medical evaluation. Regular monitoring of blood pressure and heart rate is mandatory for patients with cardiovascular diseases taking MODAHEAL.

Contraindications of MODAHEAL

MODAHEAL has a number of absolute contraindications in the presence of which the use of the drug is strictly prohibited. These include hypersensitivity to modafinil or any auxiliary component of the drug, severe cardiovascular diseases including uncontrolled hypertension, arrhythmias, ischemic heart disease, and recent myocardial infarction. The drug is not prescribed to patients with a history of psychotic disorders, as modafinil can trigger an exacerbation of psychosis or manic states. Severe hepatic impairment, liver cirrhosis, and conditions accompanied by significant left ventricular hypertrophy or mitral valve prolapse are also contraindications.

Relative contraindications to the use of MODAHEAL are epilepsy and seizure disorders, as the drug may lower the seizure threshold, as well as anxiety disorders, depression, and bipolar affective disorder. In patients with these conditions, the drug may be prescribed only after a careful benefit-risk assessment and ensuring adequate control of the underlying disease. The use of MODAHEAL during pregnancy is not recommended, as data on the safety of modafinil for the fetus are limited, and animal studies have identified a potential risk of congenital malformations. Women of childbearing potential should exclude pregnancy before starting therapy and use reliable methods of contraception throughout the entire treatment course and for at least two months after its completion.

MODAHEAL is not prescribed to children and adolescents under 18 years of age due to the lack of sufficient data on the efficacy and safety of modafinil in this age group. In elderly patients, the drug should be prescribed with caution, starting with minimal doses, as they more frequently experience liver and kidney function impairments that affect the metabolism and excretion of the active substance. Before starting MODAHEAL therapy, every patient must undergo a complete medical examination, including electrocardiography, blood pressure measurement, and laboratory studies of liver and kidney function. Only after a thorough evaluation of all risk factors can a doctor make an informed decision regarding the prescription of the drug.

Interaction of MODAHEAL with other drugs and alcohol

MODAHEAL can interact with a wide range of medicinal products due to its influence on the cytochrome P450 enzyme system, specifically on CYP3A4, CYP2C19, and CYP1A2 isoenzymes. Concomitant use with hormonal contraceptives leads to a decrease in their effectiveness due to accelerated metabolism of estrogens and progestins; therefore, female patients need to use alternative or additional methods of contraception. The drug can enhance the action of anticoagulants, such as warfarin, increasing the risk of bleeding, which requires regular monitoring of blood coagulation parameters. When used concurrently with antidepressants, particularly selective serotonin reuptake inhibitors and tricyclic antidepressants, mutual enhancement of effects and an increased risk of serotonin syndrome are possible.

Alcohol consumption during MODAHEAL therapy is strictly contraindicated, as ethanol can mask the drug's effect, leading to unpredictable reactions from the central nervous system, as well as increasing the burden on the liver and elevating the risk of toxic damage to hepatocytes. Patients taking MODAHEAL should exercise caution when driving vehicles and working with potentially dangerous machinery, especially at the beginning of treatment, as the drug can affect reaction speed and motor coordination. It is also important to inform the doctor about all medications, including over-the-counter drugs, dietary supplements, and herbal remedies taken by the patient, to avoid potentially dangerous interactions. The combination of MODAHEAL with other central nervous system stimulants, including high doses of caffeine, can lead to excessive stimulation, tachycardia, and increased blood pressure.

Where to buy MODAHEAL in Ukraine

MODAHEAL is available in Ukraine through a network of licensed pharmacy establishments that sell prescription medications in accordance with current legislation. The drug is dispensed exclusively by doctor's prescription, so to purchase it, it is necessary to first obtain a prescription following an appropriate examination and diagnosis. Patients can also use online medicine booking services through the official web platforms of pharmacy chains, allowing them to check the availability of the drug in a specific pharmacy in advance and reserve it. This approach is particularly convenient for patients living in remote regions or requiring continuous medication intake.

MODAHEAL must be stored in its original packaging at a temperature not exceeding 25 degrees Celsius in a dry place, protected from light and out of reach of children. The shelf life of the drug is usually 24 months from the date of manufacture, after which the use of the medicine is strictly prohibited. Before purchasing MODAHEAL, it is important to ensure the authenticity of the drug by checking the integrity of the packaging, the presence of protective elements, and the compliance of the batch number with the manufacturer's data. Patients are recommended to buy the drug only from verified pharmacy establishments, avoiding questionable online stores that may sell counterfeit products. Be sure to consult a doctor before starting MODAHEAL, as only a qualified specialist can determine the appropriateness of therapy, select the optimal dose, and ensure safe use of the drug taking into account individual characteristics of the body.